Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
XP13512 reduces restless legs syndrome symptoms and associated sleep impairment: Results of a double-blind, randomized, placebo-controlled study 22nd Annual Meeting of the Associated-Professional-Sleep-Societies BECKER, P., Kushida, C., Ellenbogen, A., Canafax, D., Tran, P. AMER ACAD SLEEP MEDICINE. 2008: A268–A268
View details for Web of Science ID 000255419001246